{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-20",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-20.json",
  "legislation": "uksi/2010/1614",
  "legislation_title": "The General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010",
  "path": "schedule/paragraph/20",
  "kind": "paragraph",
  "number": "20",
  "heading": "Notes and transcripts of hearings",
  "text": "(1) Subject to paragraph (3), the Committee must arrange for all hearings to be recorded in writing or electronic form.\n(2) Any party to the proceedings must, on application to the Committee and on payment of any fee determined by the Council under article 65(1) of the Order, be furnished with a transcript of the record of any part of the hearing at which that party was entitled to be present.\n(3) The private deliberations of the Committee must not be recorded.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 20 in force at 27.9.2010, see rule 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1614/schedule/paragraph/20",
    "retrieved_at": "2026-10-29T02:38:45.129905+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}